Skip to main content
FinSpry Logo
FinSpry
IBRX logo
IBRX
(NASDAQ)
ImmunityBio, Inc.
$8.05-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ImmunityBio (IBRX) Stock Price & Financial Analysis

ImmunityBio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.04 - $8.64
52-Week High$12.43
52-Week Low$1.95
Open$8.42
Volume24.68M
Average Volume (3M)13.69M
Market Cap7.14B
Shares Outstanding919.86M
Price to Sales (P/S)63.01
Price to Book (P/B)-14.29
EV/EBITDA-35.16
Revenue (TTM)113.29M
Net Income (TTM)-351.40M
Free Cash Flow (TTM)-308.78M
EPS (TTM)$-0.38
Profit Margin-310.18%
Operating Margin-226.00%
50-Day MA$7.86
200-Day MA$4.48
52-Week Change243.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ImmunityBio

What is the current stock price for IBRX?

As of the latest trading session, IBRX stock trades at $8.05. The 52-week range is $1.95–$12.43, with a day range of $8.04–$8.64.

What is the P/E ratio for IBRX?

The P/E ratio (Price-to-Earnings) for IBRX is shown in the Key Statistics section. This valuation metric helps compare ImmunityBio, Inc. to industry peers.

Does IBRX pay dividends?

ImmunityBio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IBRX?

Based on 4 analysts, the consensus for IBRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IBRX?

ImmunityBio's market capitalization is $7.40B, classifying it as a mid-cap company..